Risk Evaluation for Antipsychotic Agents Used in Elderly Inpatients (REPAIR). [PDF]
Yu F, Rafizadeh R, Mabasa VH, Kang N.
europepmc +1 more source
Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia. [PDF]
Li P +4 more
europepmc +1 more source
Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE survey. [PDF]
Velligan D +6 more
europepmc +1 more source
Douglas L Noordsy1, Glenn A Phillips2, Daniel E Ball2, Walter T Linde-Zwirble31Department of Psychiatry, Dartmouth Medical School, Lebanon, NH, USA; 2Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA; 3ZD Associates, Perkasie, PA ...
Glenn A Phillips +3 more
core
Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotic Agents for the Treatment of Patients With Schizophrenia: Results From the US DECIDE Survey. [PDF]
Velligan D +6 more
europepmc +1 more source
Gut microbiota-derived ergothioneine: a promising neuroprotective metabolite against antipsychotic-induced cognitive decline. [PDF]
Cao JW, Fan Z, Wang X.
europepmc +1 more source
Antipsychotics and Seizure Risk in Patients with Brain Tumors: Mechanisms, Modifiers, and Clinical Insights. [PDF]
Taj F, Newton HB, Alici Y.
europepmc +1 more source
Antipsychotic Drug Interactions and Short-Term Mortality Risk in People With Dementia: A National Cohort Study. [PDF]
Lau ECY +7 more
europepmc +1 more source
GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review. [PDF]
Buczkowska A +9 more
europepmc +1 more source
Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. [PDF]
Nehme H +6 more
europepmc +1 more source

